Literature DB >> 24366608

Effect of the BDNF Val66Met polymorphism on regional gray matter volumes and cognitive function in the Chinese population.

Mu-En Liu1, Chu-Chung Huang, Mu-Hong Chen, Albert C Yang, Pei-Chi Tu, Heng-Liang Yeh, Chen-Jee Hong, Jin-Fan Chen, Jen-Ping Hwang, Ching-Po Lin, Shih-Jen Tsai.   

Abstract

The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is common and influences the activity-dependent secretion of BDNF, which is critical for neuronal plasticity and survival. This study investigated the genetic effect of the BDNF Val66Met polymorphism on cognitive function and regional gray matter (GM) volume in a healthy Chinese population (n = 330). Voxel-based morphometry (VBM)-optimized analysis was used. There was no significant difference in the neuropsychological performances among the three BDNF genotypic groups. VBM analyses demonstrated that Met homozygotes had greater GM volumes than Val homozygotes in the left medial frontal gyrus, the left middle temporal gyrus, the left cerebellum, and the right middle temporal gyrus, and had larger GM volumes than Val/Met heterozygotes in the left middle temporal gyrus, the left inferior temporal gyrus, and the right superior frontal gyrus. Our findings suggest that the presence of two Met alleles has a protective effect on regional GM volumes in the Chinese population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24366608     DOI: 10.1007/s12017-013-8265-7

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  63 in total

1.  Fast and robust parameter estimation for statistical partial volume models in brain MRI.

Authors:  Jussi Tohka; Alex Zijdenbos; Alan Evans
Journal:  Neuroimage       Date:  2004-09       Impact factor: 6.556

2.  Effect of Met66 allele of the BDNF rs6265 SNP on regional gray matter volumes in patients with multiple sclerosis: A voxel-based morphometry study.

Authors:  Deepa P Ramasamy; Murali Ramanathan; Jennifer L Cox; Ronald Antulov; Bianca Weinstock-Guttman; Niels Bergsland; Ralph H B Benedict; Michael G Dwyer; Alireza Minagar; Robert Zivadinov
Journal:  Pathophysiology       Date:  2010-05-15

3.  The Val66Met coding variant of the brain-derived neurotrophic factor (BDNF) gene does not contribute toward variation in the personality trait neuroticism.

Authors:  Saffron A G Willis-Owen; Jan Fullerton; Paul G Surtees; Nick W J Wainwright; Susette Miller; Jonathan Flint
Journal:  Biol Psychiatry       Date:  2005-07-25       Impact factor: 13.382

4.  Genetic variation on the BDNF gene is not associated with differences in white matter tracts in healthy humans measured by tract-based spatial statistics.

Authors:  C Montag; J-C Schoene-Bake; J Faber; M Reuter; B Weber
Journal:  Genes Brain Behav       Date:  2010-11       Impact factor: 3.449

5.  Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression.

Authors:  L Pezawas; A Meyer-Lindenberg; A L Goldman; B A Verchinski; G Chen; B S Kolachana; M F Egan; V S Mattay; A R Hariri; D R Weinberger
Journal:  Mol Psychiatry       Date:  2008-03-18       Impact factor: 15.992

6.  The association of genotypic combination of the DRD3 and BDNF polymorphisms on the adhesio interthalamica and medial temporal lobe structures.

Authors:  Tsutomu Takahashi; Michio Suzuki; Masahiko Tsunoda; Yukiko Kawamura; Nagahide Takahashi; Nobuhisa Maeno; Yasuhiro Kawasaki; Shi-Yu Zhou; Hirofumi Hagino; Lisha Niu; Hiroshi Tsuneki; Soushi Kobayashi; Toshiyasu Sasaoka; Hikaru Seto; Masayoshi Kurachi; Norio Ozaki
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-03-25       Impact factor: 5.067

7.  Association study of brain-derived neurotrophic factor and apolipoprotein E polymorphisms and cognitive function in aged males without dementia.

Authors:  Shih-Jen Tsai; Yung-Tian A Gau; Mu-En Liu; Cheng-Hsi Hsieh; Ying-Jay Liou; Chen-Jee Hong
Journal:  Neurosci Lett       Date:  2008-01-10       Impact factor: 3.046

8.  Epistatic interactions of AKT1 on human medial temporal lobe biology and pharmacogenetic implications.

Authors:  H Y Tan; A G Chen; Q Chen; L B Browne; B Verchinski; B Kolachana; F Zhang; J Apud; J H Callicott; V S Mattay; D R Weinberger
Journal:  Mol Psychiatry       Date:  2011-07-26       Impact factor: 15.992

9.  Impact of brain-derived neurotrophic factor Val66Met polymorphism on cortical thickness and voxel-based morphometry in healthy Chinese young adults.

Authors:  Xuejuan Yang; Peng Liu; Jinbo Sun; Guihong Wang; Fang Zeng; Kai Yuan; Jixin Liu; Minghao Dong; Karen M von Deneen; Wei Qin; Jie Tian
Journal:  PLoS One       Date:  2012-06-13       Impact factor: 3.240

10.  The brain-derived neurotrophic factor Val66Met polymorphism is associated with age-related change in reasoning skills.

Authors:  S E Harris; H Fox; A F Wright; C Hayward; J M Starr; L J Whalley; I J Deary
Journal:  Mol Psychiatry       Date:  2006-05       Impact factor: 15.992

View more
  16 in total

1.  BDNF rs6265 (Val66Met) Polymorphism as a Risk Factor for Blepharospasm.

Authors:  Vasileios Siokas; Dimitrios Kardaras; Athina-Maria Aloizou; Ioannis Asproudis; Konstadinos G Boboridis; Eleni Papageorgiou; Georgios M Hadjigeorgiou; Evangelia E Tsironi; Efthimios Dardiotis
Journal:  Neuromolecular Med       Date:  2018-12-05       Impact factor: 3.843

2.  Genetic factors moderate everyday physical activity effects on executive functions in aging: Evidence from the Victoria Longitudinal Study.

Authors:  Sherilyn Thibeau; G Peggy McFall; Sandra A Wiebe; Kaarin J Anstey; Roger A Dixon
Journal:  Neuropsychology       Date:  2016-01       Impact factor: 3.295

3.  Associations Between ApoEε4 Carrier Status and Serum BDNF Levels--New Insights into the Molecular Mechanism of ApoEε4 Actions in Alzheimer's Disease.

Authors:  Yu-Hui Liu; Shu-Sheng Jiao; Ye-Ran Wang; Xian-Le Bu; Xiu-Qing Yao; Yang Xiang; Qing-Hua Wang; Lin Wang; Juan Deng; Jing Li; Xin-Fu Zhou; Hua-Dong Zhou; Yan-Jiang Wang
Journal:  Mol Neurobiol       Date:  2014-07-02       Impact factor: 5.590

4.  Combined effect of common gene variants on response to drug withdrawal therapy in medication overuse headache.

Authors:  Sarah Cargnin; Michele Viana; Grazia Sances; Marika Bianchi; Natascia Ghiotto; Cristina Tassorelli; Giuseppe Nappi; Pier Luigi Canonico; Armando A Genazzani; Salvatore Terrazzino
Journal:  Eur J Clin Pharmacol       Date:  2014-08-07       Impact factor: 2.953

5.  BDNF Val66Met Genotype Interacts With a History of Simulated Stress Exposure to Regulate Sensorimotor Gating and Startle Reactivity.

Authors:  Michael J Notaras; Rachel A Hill; Joseph A Gogos; Maarten van den Buuse
Journal:  Schizophr Bull       Date:  2017-05-01       Impact factor: 9.306

6.  The mouse-equivalent of the human BDNF VAL66MET polymorphism increases dorsal hippocampal volume and does not interact with developmental ethanol exposure.

Authors:  Clark W Bird; Megan J Barber; Jack Martin; Jacob J Mayfield; C Fernando Valenzuela
Journal:  Alcohol       Date:  2020-03-27       Impact factor: 2.405

7.  Integrating Three Characteristics of Executive Function in Non-Demented Aging: Trajectories, Classification, and Biomarker Predictors.

Authors:  H Sebastian Caballero; G Peggy McFall; Sandra A Wiebe; Roger A Dixon
Journal:  J Int Neuropsychol Soc       Date:  2020-08-10       Impact factor: 2.892

8.  The BDNF p.Val66Met polymorphism, childhood trauma, and brain volumes in adolescents with alcohol abuse.

Authors:  Shareefa Dalvie; Dan J Stein; Karestan Koenen; Valerie Cardenas; Natalie L Cuzen; Raj Ramesar; George Fein; Samantha J Brooks
Journal:  BMC Psychiatry       Date:  2014-12-16       Impact factor: 3.630

9.  Effects of the BDNF Val66Met Polymorphism on Gray Matter Volume in Typically Developing Children and Adolescents.

Authors:  Teruo Hashimoto; Kento Fukui; Hikaru Takeuchi; Susumu Yokota; Yoshie Kikuchi; Hiroaki Tomita; Yasuyuki Taki; Ryuta Kawashima
Journal:  Cereb Cortex       Date:  2016-01-31       Impact factor: 5.357

10.  Dose-dependent genotype effects of BDNF Val66Met polymorphism on default mode network in early stage Alzheimer's disease.

Authors:  Pin-Hsuan Lin; Shih-Jen Tsai; Chi-Wei Huang; Liu Mu-En; Shih-Wei Hsu; Chen-Chang Lee; Nai-Ching Chen; Ya-Ting Chang; Min-Yu Lan; Chiung-Chih Chang
Journal:  Oncotarget       Date:  2016-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.